Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gelber

Showing results (191-200 of 395) with videos related to

Pageof 40
Sort By:
Journal of the National Cancer Institute|May 21, 2019
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-AnalysisFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.
Breast Cancer Research and Treatment|February 9, 2008
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Beat Thürlimann, Karen N Price, Richard D Gelber, et al.
Frontiers in Immunology|February 13, 2024
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysisIsabella Sala, Eleonora Pagan, Laura Pala, et al.
ANZ Journal of Surgery|February 13, 2001
Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapyP R Kitchen, T H Smith, M A Henderson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 2008
Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study GroupLorenzo Gianni, Shari Gelber, Alberto Ravaioli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IXOtto Metzger-Filho, Zhuoxin Sun, Giuseppe Viale, et al.
The New England Journal of Medicine|September 11, 1986
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemiaL A Clavell, R D Gelber, H J Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study GroupM Castiglione-Gertsch, M Tattersall, A Hacking, et al.
Breast Cancer Research and Treatment|January 13, 2009
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a centuryOlivia Pagani, Karen N Price, Richard D Gelber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVDiana Crivellari, Karen Price, Richard D Gelber, et al.
Pageof 40

Showing results (191-200 of 395) with videos related to

Sort By:
Pageof 40
Journal of the National Cancer Institute|May 21, 2019
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-AnalysisFabio Conforti, Laura Pala, Vincenzo Bagnardi, et al.
Breast Cancer Research and Treatment|February 9, 2008
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Beat Thürlimann, Karen N Price, Richard D Gelber, et al.
Frontiers in Immunology|February 13, 2024
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysisIsabella Sala, Eleonora Pagan, Laura Pala, et al.
ANZ Journal of Surgery|February 13, 2001
Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapyP R Kitchen, T H Smith, M A Henderson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 2008
Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study GroupLorenzo Gianni, Shari Gelber, Alberto Ravaioli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IXOtto Metzger-Filho, Zhuoxin Sun, Giuseppe Viale, et al.
The New England Journal of Medicine|September 11, 1986
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemiaL A Clavell, R D Gelber, H J Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study GroupM Castiglione-Gertsch, M Tattersall, A Hacking, et al.
Breast Cancer Research and Treatment|January 13, 2009
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a centuryOlivia Pagani, Karen N Price, Richard D Gelber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVDiana Crivellari, Karen Price, Richard D Gelber, et al.
Pageof 40